DE60118593D1 - Verfahren zur herstellung von kristallinem n-formimidoylthienamycin-monohydrat (imipenem-monohydrat) - Google Patents

Verfahren zur herstellung von kristallinem n-formimidoylthienamycin-monohydrat (imipenem-monohydrat)

Info

Publication number
DE60118593D1
DE60118593D1 DE60118593T DE60118593T DE60118593D1 DE 60118593 D1 DE60118593 D1 DE 60118593D1 DE 60118593 T DE60118593 T DE 60118593T DE 60118593 T DE60118593 T DE 60118593T DE 60118593 D1 DE60118593 D1 DE 60118593D1
Authority
DE
Germany
Prior art keywords
monohydrate
formimidoylthienamycin
imipenem
preparing crystalline
crystalline
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60118593T
Other languages
German (de)
English (en)
Inventor
Yatendra Kumar
Neera Tewari
Ram Chander Aryan
Bishwa Prakash Rai
Seema Ahuja
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ranbaxy Laboratories Ltd
Original Assignee
Ranbaxy Laboratories Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=11097114&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DE60118593(D1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Ranbaxy Laboratories Ltd filed Critical Ranbaxy Laboratories Ltd
Application granted granted Critical
Publication of DE60118593D1 publication Critical patent/DE60118593D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D477/00—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring
    • C07D477/10—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2
    • C07D477/12—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached in position 6
    • C07D477/16—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached in position 6 with hetero atoms or carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 3
    • C07D477/20—Sulfur atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
DE60118593T 2000-11-03 2001-11-05 Verfahren zur herstellung von kristallinem n-formimidoylthienamycin-monohydrat (imipenem-monohydrat) Expired - Lifetime DE60118593D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IN983DE2000 IN191798B (forum.php) 2000-11-03 2000-11-03
PCT/IB2001/002069 WO2002036594A1 (en) 2000-11-03 2001-11-05 Process for the preparation of crystalline n-formimidoyl thienamycin monohydrate (imipenem monohydrate)

Publications (1)

Publication Number Publication Date
DE60118593D1 true DE60118593D1 (de) 2006-05-18

Family

ID=11097114

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60118593T Expired - Lifetime DE60118593D1 (de) 2000-11-03 2001-11-05 Verfahren zur herstellung von kristallinem n-formimidoylthienamycin-monohydrat (imipenem-monohydrat)

Country Status (19)

Country Link
US (1) US7078534B2 (forum.php)
EP (1) EP1334105B1 (forum.php)
JP (1) JP2004525084A (forum.php)
KR (1) KR20030059812A (forum.php)
CN (1) CN100445284C (forum.php)
AT (1) ATE322495T1 (forum.php)
AU (1) AU2002212591A1 (forum.php)
BG (1) BG107852A (forum.php)
CA (1) CA2427762C (forum.php)
DE (1) DE60118593D1 (forum.php)
DK (1) DK1334105T3 (forum.php)
EA (1) EA006442B1 (forum.php)
EE (1) EE200300206A (forum.php)
ES (1) ES2261494T3 (forum.php)
IN (1) IN191798B (forum.php)
MX (1) MXPA03003916A (forum.php)
PT (1) PT1334105E (forum.php)
WO (1) WO2002036594A1 (forum.php)
ZA (1) ZA200303338B (forum.php)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2328117T3 (es) * 2001-05-18 2009-11-10 Ranbaxy Laboratories Limited Proceso para la preparacion de imipenem.
NZ529625A (en) * 2001-05-18 2006-02-24 Ranbaxy Lab Ltd Process for the preparation of amorphous cilastatin sodium
CN1522255A (zh) 2001-05-18 2004-08-18 ʵ 结晶亚胺培南的分离方法
WO2003016312A1 (fr) * 2001-08-13 2003-02-27 Eisai Co., Ltd. Procede de preparation d'antibiotiques a base de carbapenem
MXPA04004604A (es) 2001-11-16 2004-09-10 Ranbaxy Lab Ltd Proceso para la preparacion de imipenem cristalino.
US6537985B1 (en) * 2001-11-30 2003-03-25 Phoenix Scientific, Inc. Antibiotic formulation and a method of making this formulation
KR100667373B1 (ko) * 2003-12-09 2007-01-10 주식회사 중외제약 이미페넴의 신규 제조방법
KR100848752B1 (ko) * 2006-11-10 2008-07-25 제일약품주식회사 티에나마이신 용매화합물 및 그의 제조방법
KR100848751B1 (ko) * 2006-11-10 2008-07-25 제일약품주식회사 이미페넴의 제조방법
WO2009047604A1 (en) * 2007-10-08 2009-04-16 Orchid Chemicals & Pharmaceuticals Limited Process for the preparation of carbapenem antibiotic
CN108623598A (zh) * 2018-05-21 2018-10-09 重庆天地药业有限责任公司 一种亚胺培南中间体及亚胺培南的制备方法
CN111413427A (zh) * 2020-04-08 2020-07-14 苏州和合医学检验有限公司 超滤前处理高效液相色谱测定血浆中亚胺培南含量的方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4194047A (en) * 1975-11-21 1980-03-18 Merck & Co., Inc. Substituted N-methylene derivatives of thienamycin
US4260543A (en) * 1978-07-03 1981-04-07 Merck & Co., Inc. Crystalline N-formimidoyl thienamycin
JP3048196B2 (ja) 1991-06-20 2000-06-05 第一製薬株式会社 カルバペネム誘導体
FI941490A7 (fi) 1991-10-01 1994-05-02 Procter & Gamble Pharmaceuticals Inc Menetelmä mikrobien vastaisten kinolonyylilaktaamien valmistamiseksi
NO304981B1 (no) 1992-09-09 1999-03-15 Sankyo Co FremgangsmÕte for fremstilling av karbapenem- og penemforbindelser, samt nye forbindelser involvert i fremgangsmÕten
US5245069A (en) * 1992-10-27 1993-09-14 Merck & Co., Inc. Process for the preparation of bis(aryl)-phosphorohalidates
US5872250A (en) * 1997-07-30 1999-02-16 Merck & Co., Inc. Process for synthesizing carbapenem antibiotics

Also Published As

Publication number Publication date
CN100445284C (zh) 2008-12-24
EP1334105B1 (en) 2006-04-05
ZA200303338B (en) 2004-03-09
ATE322495T1 (de) 2006-04-15
MXPA03003916A (es) 2004-01-29
US20040054167A1 (en) 2004-03-18
IN191798B (forum.php) 2004-01-03
US7078534B2 (en) 2006-07-18
EA200300520A1 (ru) 2003-10-30
CN1481384A (zh) 2004-03-10
EP1334105A1 (en) 2003-08-13
CA2427762A1 (en) 2002-05-10
JP2004525084A (ja) 2004-08-19
CA2427762C (en) 2009-10-20
BG107852A (bg) 2004-01-30
KR20030059812A (ko) 2003-07-10
EE200300206A (et) 2003-10-15
ES2261494T3 (es) 2006-11-16
AU2002212591A1 (en) 2002-05-15
WO2002036594A1 (en) 2002-05-10
PT1334105E (pt) 2006-08-31
DK1334105T3 (da) 2006-08-14
EA006442B1 (ru) 2005-12-29

Similar Documents

Publication Publication Date Title
DE60141706D1 (de) Verbindungen mit fungizider wirkung und verfahren zur ihrer herstellung und verwendung
DE60118593D1 (de) Verfahren zur herstellung von kristallinem n-formimidoylthienamycin-monohydrat (imipenem-monohydrat)
DE60114002D1 (de) VERFAHREN ZUR HERSTELLUNG KRISTALLINEr PARTIKEL ZUR INHALATION
ATE318139T1 (de) Dipeptidylpeptidase-hemmer zur behandlung von diabetes
WO2004013120A8 (en) Novel benzodioxoles
BR0316375A (pt) Diazinopirimidinas
MXPA05010433A (es) Derivados de pirrolidina y procedimiento para prepararlos.
MXPA04004604A (es) Proceso para la preparacion de imipenem cristalino.
MXPA05009688A (es) Derivados de naftiridina como agentes antibacterianos.
DE60236207D1 (de) Verfahren zur herstellung von phenserin und dessen analogon
DE69937143D1 (de) Verfahren zur reinigung eines cephalosporin-derivats
DE60125378D1 (de) Verfahren zur herstellung von 2-aminomethyl-halogen-pyridinen
DE60015563D1 (de) Verfahren zur herstellung von benzoperhydroisoindolen
ATE266618T1 (de) Verfahren zur herstellung von zwischenprodukten für pestizide
ATE292135T1 (de) Neues verfahren zur herstellung von vinyl- pyrrolidinon cephalosporin derivate
DE60233130D1 (de) Verfahren zur herstellung von imipenem
ATE549315T1 (de) Verfahren zur herstellung von kristallinem perindopril
DE602004008486D1 (de) Verfahren zur herstellung von (1s,4r)-cis-4-ä2-amino-6-chlor-9h-purin-9-ylü-2-cyclopenten-1-methanol
MXPA03010548A (es) Proceso para el aislamiento de imipenem cristalino.
ATE299851T1 (de) Verfahren zur herstellung von zwischenprodukten
DE60107292D1 (de) Verfahren zur herstellung von (+)-trans-4-p-fluorophenyl-3-hydroxymethyl-1-methylpiperidin
IL148161A0 (en) Process for the preparation of 2-cyanopyridines
DE60325390D1 (de) Verfahren zur herstellung von zwischenprodukten
MY134151A (en) Process for the preparation of crystalline n-formimindoyl thienamycin monohydrate (imipenem monohydrate)
MXPA06001115A (es) Un proceso nuevo para la preparacion de imipenem.

Legal Events

Date Code Title Description
8332 No legal effect for de